Broncus Holding Corporation (HKG:2216)
2.440
+0.270 (12.44%)
Jun 12, 2025, 4:08 PM HKT
Broncus Holding Revenue
In the year 2024, Broncus Holding had annual revenue of $8.13M USD, down -20.71%. Broncus Holding had revenue of $4.43M in the half year ending December 31, 2024, a decrease of -28.54%.
Revenue
$8.13M
Revenue Growth
-20.71%
P/S Ratio
20.30
Revenue / Employee
$40.66K
Employees
200
Market Cap
1.28B HKD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 32.53B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
Innovent Biologics | 10.03B |
CSPC Pharmaceutical Group | 28.99B |
WuXi Biologics | 19.87B |
Sino Biopharmaceutical | 30.72B |
Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |